CGEN COMPUGEN LTD

Nasdaq cgen.com


$ 1.67 $ -0.01 (-0.6 %)    

Thursday, 13-Nov-2025 11:25:37 EST
QQQ $ 610.28 $ -7.40 (-1.2 %)
DIA $ 477.80 $ -3.59 (-0.74 %)
SPY $ 674.44 $ -6.04 (-0.89 %)
TLT $ 89.75 $ -0.05 (-0.06 %)
GLD $ 386.35 $ -1.01 (-0.26 %)
$ 1.68
$ 1.68
$ 1.66 x 210
$ 1.68 x 400
$ 1.67 - $ 1.71
$ 1.13 - $ 2.66
285,101
na
150.43M
$ 1.59
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 compugen-q3-eps-007-beats-009-estimate-sales-1891m-beat-1469m-estimate

Compugen (NASDAQ:CGEN) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.09) by 1...

 compugen-publishes-pooled-data-showing-com701-activity-in-platinum-resistant-ovarian-cancer-ahead-of-esmo-presentation

 Compugen Ltd. (NASDAQ:CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in predictive computation...

 compugen-q2-eps-008-misses-007-estimate-sales-1257m-miss-3952m-estimate

Compugen (NASDAQ:CGEN) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $(0.07) by...

 compugen-q1-eps-008-misses-006-estimate-sales-228m-miss-370m-estimate

Compugen (NASDAQ:CGEN) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $(0.06) by...

 compugen-q4-2024-gaap-eps-007-may-not-be-comparable-to-007-estimate-sales-147m-may-not-be-comparable-to-1743m-estimate

Compugen (NASDAQ:CGEN) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $0.07 by 2...

 compugen-expands-its-intellectual-property-portfolio-with-new-us-patent-covering-triple-combination-use-of-com902-reduced-fc-anti-tigit-with-anti-pd-1-and-anti-pvrig-antibodies

The company announced that the United States Patent and Trademark Office (USPTO) has granted the Company a new patent covering ...

 compugen-q3-2024-gaap-eps-001-misses-006-estimate-sales-17132m-miss-17862m-estimate

Compugen (NASDAQ:CGEN) reported quarterly earnings of $0.01 per share which missed the analyst consensus estimate of $0.06 by 8...

 compugen-q2-eps-002-beats-007-estimate-sales-670m

Compugen (NASDAQ:CGEN) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.07) by 7...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION